Influence of bacterial metabolites on the systemic antitumor immune response after radiotherapy in combination with immune checkpoint inhibitors

被引:0
|
作者
Felchle, Hannah [1 ]
Gissibl, Julia [1 ]
Rotgerink, Laura Lansink [1 ]
Nefzger, Sophie M. [1 ]
Walther, Caroline N. [1 ]
Combs, Stephanie E. [1 ,2 ]
Fischer, Julius C. [1 ]
机构
[1] Tech Univ Munich, Klin & Poliklin Radioonkol & Strahlentherapie, Munich, Germany
[2] Helmholtz Zentrum Munchen, Inst Strahlenmed IRM, Munich, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
VS14-5-jD
引用
收藏
页码:S49 / S49
页数:1
相关论文
共 50 条
  • [21] Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
    Lhuillier, Claire
    Vanpouille-Box, Claire
    Galluzzi, Lorenzo
    Formenti, Silvia Chiara
    Demaria, Sandra
    SEMINARS IN CANCER BIOLOGY, 2018, 52 : 125 - 134
  • [22] Changes in systemic immune response after stereotactic ablative radiotherapy
    Rutkowski, Jacek
    Slebioda, Tomasz
    Kmiec, Zbigniew
    Zaucha, Renata
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (04): : 245 - 253
  • [23] Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
    Yang Liu
    Yinping Dong
    Li Kong
    Fang Shi
    Hui Zhu
    Jinming Yu
    Journal of Hematology & Oncology, 11
  • [24] Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
    Liu, Yang
    Dong, Yinping
    Kong, Li
    Shi, Fang
    Zhu, Hui
    Yu, Jinming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [25] Overview of the molecular interactions between radiotherapy and the immune system and immune checkpoint inhibitors
    Melcher, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S177 - S177
  • [26] Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?
    Rizzo, Alessandro
    Cusmai, Antonio
    Ricci, Angela Dalia
    Brandi, Giovanni
    Palmiotti, Gennaro
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (04) : 307 - 310
  • [27] Carbon Therapy in Combination with Immune Checkpoint Inhibitors induces Antitumor defects in local and distal Tumors
    Helm, A.
    Simoniello, P.
    Tinganelli, W.
    Kurosawa, F.
    Fournier, C.
    Shimokawa, T.
    Durante, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S28 - S28
  • [28] Response to a combination of erlotinib and bevacizumab therapy after immune checkpoint inhibitor
    Okauchi, Shinichiro
    Miyazaki, Kunihiko
    Yamada, Hideyasu
    Satoh, Hiroaki
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (05): : 500 - 501
  • [29] Antitumor Effects of Combination Immune Checkpoint Inhibitors and DPP4 Inhibitors in Advanced Renal Cell Carcinoma
    Daizumoto, Kei
    Uto, Yoshihiro
    Uehara, Hisanori
    Fukawa, Tomoya
    Takahashi, Masayuki
    CANCER SCIENCE, 2025, 116 : 966 - 966
  • [30] Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy
    Zhao, Xianda
    Subramanian, Subbaya
    PHARMACOLOGY & THERAPEUTICS, 2018, 181 : 76 - 84